M. Girard, P. Duquette, W. Sibley (1993)
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.Neurology
E. Waubant, L. Gee, P. Bacchetti, R. Sloan, A. Cotleur, R. Rudick, D. Goodkin (2001)
Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MSJournal of Neuroimmunology, 112
M. Clanet, E. Radue, L. Kappos, Hans-Peter Hartung, R. Hohlfeld, M. Sandberg-wollheim, M. Kooijmans-Coutinho, E. Tsao, A. Sandrock (2002)
A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MSNeurology, 59
P. Rieckmann, M. Albrecht, B. Kitze, T. Weber, H. Tumani, A. Broocks, W. Lüer, S. Poser (1994)
Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosisNeurology, 44
A. Byrnes, J. Mcarthur, C. Karp (2002)
Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production.Annals of neurology, 51 2
A. D’Andrea, M. Aste‐Amezaga, N. Valiante, Xiaojing Ma, M. Kubin, G. Trinchieri (1993)
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cellsThe Journal of Experimental Medicine, 178
C. Poser, D. Paty, L. Scheinberg, W. Mcdonald, F. Davis, G. Ebers, K. Johnson, W. Sibley, D. Silberberg, W. Tourtellotte (1983)
New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 13
S. Adikari, Å. Pettersson, M. Soderstrom, Ym Huang, H. Link (2004)
Interleukin‐10‐Modulated Immature Dendritic Cells Control the Proinflammatory Environment in Multiple SclerosisScandinavian Journal of Immunology, 59
J. Beck, P. Rondot, L. Catinot, E. Falcoff, H. Kirchner, J. Wietzerbin (1988)
Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?Acta Neurologica Scandinavica, 78
B. Becher, P. Giacomini, D. Pelletier, E. Mccrea, A. Prat, J. Antel (1999)
Interferon‐γ secretion by peripheral blood T‐cell subsets in multiple sclerosis: Correlation with disease phase and interferon‐β therapyAnnals of Neurology, 45
J. Graber, M. Zhan, D. Ford, F. Kursch, G. Francis, C. Bever, H. Panitch, P. Calabresi, S. Dhib-Jalbut, S. Dhib-Jalbut (2005)
Interferon-β-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosisJournal of Neuroimmunology, 161
J. Simon, L. Jacobs, M. Campion, R. Rudick, D. Cookfair, R. Herndon, J. Richert, A. Salazar, J. Fischer, D. Goodkin, N. Simonian, M. Lajaunie, D. Miller, Wende Ke, A. Martens-Davidson, R. Kinkel, F. Munschauer, C. Brownscheidle (1999)
A longitudinal study of brain atrophy in relapsing multiple sclerosisNeurology, 53
B. Segal, E. Shevach (1996)
IL-12 unmasks latent autoimmune disease in resistant miceThe Journal of Experimental Medicine, 184
Yang Liu, C. Janeway (1990)
Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-toleranceThe Journal of Experimental Medicine, 172
S. Jander, G. Stoll (1998)
Differential induction of interleukin-12, interleukin-18, and interleukin-1β converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis ratJournal of Neuroimmunology, 91
Jorge Correale, W. Gilmore, Minnie McMillan, S. Li, K. Mccarthy, T. Le, Leslie Weiner (1995)
Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis.Journal of immunology, 154 6
E. Ersoy, C. Kus, U. Şener, I. Çoker, Y. Zorlu (2005)
The effects of interferon‐β on interleukin‐10 in multiple sclerosis patientsEuropean Journal of Neurology, 12
Xin Wang, Man Chen, K. Wandinger, Gary Williams, S. Dhib-Jalbut (2000)
IFN-β-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-β-1b Therapeutic Effects in Multiple Sclerosis1The Journal of Immunology, 165
P. Calabresi, L. Stone, C. Bash, Joseph Frank, H. McFarland (1997)
Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRINeurology, 48
H. Panitch, A. Haley, R. Hirsch, K. Johnson (1987)
EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONThe Lancet, 329
A. Windhagen, J. Newcombe, F. Dangond, C. Strand, M. Woodroofe, M. Cuzner, D. Hafler (1995)
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesionsThe Journal of Experimental Medicine, 182
K. Makhlouf, H. Weiner, S. Khoury (2001)
Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MSJournal of Neuroimmunology, 119
A. Boxel-Dezaire, A. Boxel-Dezaire, S. Trigt-Hoff, J. Killestein, H. Schrijver, J. Houwelingen, C. Polman, L. Nagelkerken (2000)
Contrasting responses to interferon β‐1b treatment in relapsing‐remitting multiple sclerosis: Does baseline interleukin‐12p35 messenger RNA predict the efficacy of treatment?Annals of Neurology, 48
L. Durelli, E. Verdun, P. Barbero, M. Bergui, E. Versino, A. Ghezzi, E. Montanari, M. Zaffaroni (2002)
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)The Lancet, 359
J. Leonard, K. Waldburger, Samuel Goldman (1995)
Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12The Journal of Experimental Medicine, 181
A. Berghella, R. Totaro, P. Pellegrini, I. Contasta, T. Russo, A. Carolei, D. Adorno (2005)
Immunological Study of IFNβ-1a-Treated and Untreated Multiple Sclerosis Patients: Clarifying IFNβ Mechanisms and Establishing Specific Dendritic Cell ImmunotherapyNeuroimmunomodulation, 12
D. Cua, H. Groux, D. Hinton, S. Stohlman, R. Coffman (1999)
Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 189
D. Paty, D. Li (1993)
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 43
G. Ebers (1998)
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosisThe Lancet, 352
S. Šega, B. Wraber, A. Mesec, A. Horvat, A. Ihan (2004)
IFN-β1a and IFN-β1b have different patterns of influence on cytokinesClinical Neurology and Neurosurgery, 106
H. Petereit, S. Nolden, S. Schoppe, S. Bamborschke, R. Pukrop, WD Heiss (2002)
Low interferon gamma producers are better treatment responders: a two-year follow-up of interferon beta-treated multiple sclerosis patientsMultiple Sclerosis, 8
M. Luomala, T. Lehtimäki, H. Huhtala, M. Ukkonen, T. Koivula, M. Hurme, I. Elovaara (2003)
Promoter polymorphism of IL‐10 and severity of multiple sclerosisActa Neurologica Scandinavica, 108
A. Boxel-Dezaire, S. Hoff, B. Oosten, C. Verweij, A. Dräger, H. Adèr, J. Houwelingen, F. Barkhof, C. Polman, L. Nagelkerken (1999)
Decreased interleukin‐10 and increased interleukin‐12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosisAnnals of Neurology, 45
J. Imitola, T. Chitnis, S. Khoury (2005)
Cytokines in multiple sclerosis: from bench to bedside.Pharmacology & therapeutics, 106 2
H. Groux, M. Bigler, Jan Devries, M. Roncarolo (1996)
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cellsThe Journal of Experimental Medicine, 184
O. Rott, B. Fleischer, E. Cash (1994)
Interleukin‐10 prevents experimental allergic encephalomyelitis in ratsEuropean Journal of Immunology, 24
V. Badovinac, Amy Tvinnereim, J. Harty (2000)
Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma.Science, 290 5495
R. Rudick, R. Ransohoff, R. Peppler, S. Medendorp, P. Lehmann, J. Alam (1996)
Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosisAnnals of Neurology, 40
R. Furlan, A. Bergami, R. Lang, E. Brambilla, D. Franciotta, V. Martinelli, G. Comi, P. Panina, G. Martino (2000)
Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4Journal of Neuroimmunology, 111
T. Yednock, C. Cannon, L. Fritz, F. Sánchez‐Madrid, L. Steinman, N. Karin (1992)
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 356
A. Beebe, D. Cua, R. Malefyt (2002)
The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).Cytokine & growth factor reviews, 13 4-5
R. Rudick, R. Ransohoff, Jar‐chi Lee, R. Peppler, Min Yu, P. Mathisen, V. Tuohy (1998)
In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosisNeurology, 50
S. Wergeland, A. Beiske, H. Nyland, H. Hovdal, D. Jensen, J. Larsen, T. Maroy, A. Smievoll, C. Vedeler, K. Myhr (2005)
IL‐10 promoter haplotype influence on interferon treatment response in multiple sclerosisEuropean Journal of Neurology, 12
E. Bettelli, M. Das, E. Howard, H. Weiner, R. Sobel, V. Kuchroo (1998)
IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic miceJournal of Neuroimmunology, 90
Dale McFarlin, Susan Blank, Robert Kibler (1974)
Recurrent experimental allergic encephalomyelitis in the Lewis rat.Journal of immunology, 113 2
T. Smith, A. Hewson, C. Kingsley, J. Leonard, M. Cuzner (1997)
Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.The American journal of pathology, 150 6
C. Pelfrey, R. Rudick, A. Cotleur, Jar‐chi Lee, M. Tary‐Lehmann, P. Lehmann (2000)
Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production1The Journal of Immunology, 165
M. Roncarolo, R. Bacchetta, C. Bordignon, S. Narula, M. Levings (2001)
Type 1 T regulatory cellsImmunological Reviews, 182
Journal of Neuroimmunology – Unpaywall
Published: Feb 28, 2007
Access the full text.
Sign up today, get DeepDyve free for 14 days.